Researchers from Barcelona’s Hospital Clínic and the University of Oviedo (Asturias) have sequenced Chronic Lymphocytic Leukaemia’s entire genome for the first time. Mutations in four genes have been identified as one of the illness triggers. The study was published last Sunday in the prestigious journal ‘Nature’.
An international study led by a Catalan team of researchers finds that the vaccine is not only effective in women between the ages of 9 and 26 , but in women older than 26. Women up to 45 years old could use this preventative vaccine. The study is published this Wednesday in the ‘British Journal of Cancer’.
The new drug, called ‘Eribulin’, improves the survival rate of patients with a metastasis from breast cancer by 20%. The drug has been developed by a multinational team lead by staff from Barcelona’s Vall d’Hebron Hospital. The study has been published in the reference medical journal ‘The Lancet’.
A new technique has been put into place that enables more precise irradiations, affecting surrounding organs less and thus minimising secondary effects. The Catalan monographic hospital is the 2nd in Spain to use this technique.
The new Research Unit for Molecular Therapy at the Vall d'Hebron Hospital will be able to treat 400 patients a year. It will study each particular tumour differently, on a case per case basis, and analyse it?s genome.